Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more
Laobaixing Pharmacy (603883) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.075x
Based on the latest financial reports, Laobaixing Pharmacy (603883) has a cash flow conversion efficiency ratio of 0.075x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥538.25 Million) by net assets (CN¥7.20 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Laobaixing Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Laobaixing Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Laobaixing Pharmacy Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laobaixing Pharmacy ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cellcom Israel Ltd
PINK:CELJF
|
0.033x |
|
Beijing Hualian Hypermarket Co Ltd
SHG:600361
|
0.029x |
|
Global Infotech Co Ltd
SHE:300465
|
0.022x |
|
Honeywell Automation India Limited
NSE:HONAUT
|
0.058x |
|
Core Laboratories NV
NYSE:CLB
|
0.028x |
|
Hyundai Department
KO:069960
|
0.049x |
|
TSEC Corp
TW:6443
|
0.010x |
|
Sunway Construction Group Bhd
KLSE:5263
|
0.546x |
Annual Cash Flow Conversion Efficiency for Laobaixing Pharmacy (2011–2024)
The table below shows the annual cash flow conversion efficiency of Laobaixing Pharmacy from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.17 Billion | CN¥2.03 Billion | 0.283x | -24.52% |
| 2023-12-31 | CN¥7.29 Billion | CN¥2.73 Billion | 0.375x | +14.86% |
| 2022-12-31 | CN¥7.10 Billion | CN¥2.31 Billion | 0.326x | -32.20% |
| 2021-12-31 | CN¥4.78 Billion | CN¥2.30 Billion | 0.481x | +59.66% |
| 2020-12-31 | CN¥4.81 Billion | CN¥1.45 Billion | 0.301x | +13.04% |
| 2019-12-31 | CN¥3.87 Billion | CN¥1.03 Billion | 0.266x | -1.66% |
| 2018-12-31 | CN¥3.37 Billion | CN¥913.03 Million | 0.271x | +70.76% |
| 2017-12-31 | CN¥3.10 Billion | CN¥492.13 Million | 0.159x | -1.45% |
| 2016-12-31 | CN¥1.95 Billion | CN¥313.26 Million | 0.161x | +43.53% |
| 2015-12-31 | CN¥2.29 Billion | CN¥257.15 Million | 0.112x | -50.72% |
| 2014-12-31 | CN¥1.09 Billion | CN¥247.14 Million | 0.228x | +52.82% |
| 2013-12-31 | CN¥916.46 Million | CN¥136.52 Million | 0.149x | -26.69% |
| 2012-12-31 | CN¥732.59 Million | CN¥148.85 Million | 0.203x | -6.94% |
| 2011-12-31 | CN¥607.41 Million | CN¥132.62 Million | 0.218x | -- |